DONNINI, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 11.218
EU - Europa 8.376
AS - Asia 4.886
SA - Sud America 697
AF - Africa 205
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 25.398
Nazione #
US - Stati Uniti d'America 11.081
GB - Regno Unito 2.090
RU - Federazione Russa 1.607
CN - Cina 1.567
SG - Singapore 1.488
IE - Irlanda 1.130
IT - Italia 882
SE - Svezia 625
VN - Vietnam 615
BR - Brasile 604
UA - Ucraina 584
FR - Francia 488
DE - Germania 433
HK - Hong Kong 395
FI - Finlandia 249
IN - India 236
KR - Corea 228
BD - Bangladesh 78
ZA - Sudafrica 75
CA - Canada 71
TR - Turchia 67
ES - Italia 58
NL - Olanda 51
MX - Messico 41
PL - Polonia 38
NG - Nigeria 36
AR - Argentina 35
BE - Belgio 35
IQ - Iraq 35
CI - Costa d'Avorio 31
JP - Giappone 23
AT - Austria 21
ID - Indonesia 19
MA - Marocco 17
PK - Pakistan 16
NP - Nepal 14
EC - Ecuador 13
IL - Israele 12
UZ - Uzbekistan 12
KE - Kenya 11
VE - Venezuela 11
DZ - Algeria 10
LT - Lituania 10
AU - Australia 9
CO - Colombia 9
CZ - Repubblica Ceca 9
PH - Filippine 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
BG - Bulgaria 7
PT - Portogallo 7
RO - Romania 7
SA - Arabia Saudita 7
GR - Grecia 6
JO - Giordania 6
AZ - Azerbaigian 5
BO - Bolivia 5
BY - Bielorussia 5
DK - Danimarca 5
EG - Egitto 5
ET - Etiopia 5
HU - Ungheria 5
IR - Iran 5
KG - Kirghizistan 5
OM - Oman 5
PE - Perù 5
RS - Serbia 5
TT - Trinidad e Tobago 5
CR - Costa Rica 4
EU - Europa 4
HN - Honduras 4
LU - Lussemburgo 4
TW - Taiwan 4
UY - Uruguay 4
BH - Bahrain 3
GT - Guatemala 3
KH - Cambogia 3
KZ - Kazakistan 3
LK - Sri Lanka 3
MM - Myanmar 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EE - Estonia 2
LB - Libano 2
LV - Lettonia 2
MN - Mongolia 2
MY - Malesia 2
NI - Nicaragua 2
PA - Panama 2
PY - Paraguay 2
AL - Albania 1
AO - Angola 1
BM - Bermuda 1
BS - Bahamas 1
BW - Botswana 1
Totale 25.385
Città #
Southend 1.867
Dallas 1.279
Dublin 1.114
Fairfield 1.073
Ashburn 915
Singapore 893
Chandler 639
Houston 593
San Jose 571
Woodbridge 496
Jacksonville 487
Santa Clara 453
Seattle 417
Wilmington 416
Moscow 412
Hong Kong 370
Beijing 367
Cambridge 353
Hefei 277
Ann Arbor 261
Seoul 227
Princeton 226
Siena 225
Los Angeles 170
The Dalles 159
Dong Ket 154
Menlo Park 147
Ho Chi Minh City 140
Nanjing 135
Council Bluffs 124
Hanoi 117
Helsinki 114
Lauterbourg 111
Milan 110
Pune 101
New York 99
Munich 89
Boardman 85
Florence 85
San Diego 79
Fremont 66
San Mateo 66
Johannesburg 60
Columbus 58
Buffalo 55
Bengaluru 52
São Paulo 44
Tianjin 40
Redondo Beach 39
London 38
Orem 38
Nanchang 37
Turku 36
Brussels 35
Da Nang 35
Shenyang 35
Kunming 34
Rome 34
Abuja 33
Izmir 33
Shanghai 32
Abidjan 31
Dearborn 31
Warsaw 31
Hebei 30
Málaga 30
Chicago 29
Nuremberg 27
Brooklyn 26
Chennai 26
Frankfurt am Main 26
San Francisco 24
Toronto 23
Tokyo 22
Amsterdam 21
Atlanta 21
Lancaster 21
Haiphong 20
Jinan 20
Manchester 20
Phoenix 20
Prato 20
Changsha 19
Hangzhou 19
Mexico City 19
Montreal 19
Zhengzhou 19
Denver 18
Norwalk 17
Düsseldorf 16
Guangzhou 16
Padua 15
Belo Horizonte 14
Jiaxing 14
Naples 14
Poplar 14
Stockholm 14
Vienna 14
Brasília 13
Falls Church 13
Totale 17.656
Nome #
Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis 438
Formulation of liposomes functionalized with the Lotus lectin and effective in targeting highly proliferative cells 418
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 348
ALDH2 activity reduces mitochondrial oxygen reserve capacity in endothelial cells and induces senescence properties 328
Involvement of bradykinin B2 receptor in pathological vascularization in oxygen-induced retinopathy in mice and rabbit cornea 309
Yeast-derived recombinant avenanthramides inhibit proliferation, migration and epithelial mesenchymal transition of colon cancer cells 306
Monitoring endothelial and tissue responses to cobalt ferrite Nanoparticles and Hybrid Hydrogels 301
Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells 295
EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity 294
Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation 291
Targeting endothelial-to-mesenchymal transition: the protective role of hydroxytyrosol sulfate metabolite 291
PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells 268
Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation. 265
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 265
Angiogenic polypeptides in breast cancer: expression of MRNA’s in primary human tumours, MCF-7 cell transfection and xenograft models 259
Aquaporin Membrane Channels in Oxidative Stress, Cell Signaling, and Aging: Recent Advances and Research Trends 259
PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells 256
Divergent effects of quercetin conjugates on angiogenesis 254
mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines 254
Bradykinin B2 receptor contributes to inflammatory responses in human endothelial cells by the transactivation of the fibroblast growth factor receptor FGFR-1 250
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers 249
Abolished angiogenicity and tumorigenicity of Burkitt's lymphoma by Interleukin-10 246
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing 246
Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data 245
Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin 242
Biological characterization of nanocomposite hydrogels 241
RNA-mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation 240
Development of phenol-enriched olive oil with phenolic compounds extracted from wastewater produced by physical refining 240
Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4 240
Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer 236
Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review 236
Targeting PGE2 Signaling in Tumor Progression and Angiogenesis 232
Studying vascular angiogenesis and senescence in zebrafish embryos 232
Activity of "NO-donor" or "NO-mediated" drugs 231
miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction 229
ALDH1A1 confers resistance to RAF/MEK inhibitors in melanoma cells by maintaining stemness phenotype and activating PI3K/AKT signaling 227
Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor 222
EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways 222
Dbl oncogene expression in MCF-10 A epithelial cells disrupts mammary acinar architecture, induces EMT and angiogenic factor secretion 221
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line 219
How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance 214
Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells 212
ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL‑8/Notch signaling cascade 212
A novel protein from the serum of Python sebae, structurally homologous with type-γ phospholipase A2 inhibitor, displays antitumour activity 211
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells 211
Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells 208
Assessing vascular senescence in zebrafish 207
Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling 207
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 207
An angiogenic role for the neurotrophins midkine and pleiotrophin in tumorigenesis. 206
Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants 205
MPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity 205
Abeta peptides accelerate the senescence of endothelial cells in vitro and in vivo, impairing angiogenesis 204
Role of nitric oxide in the modulation of angiogenesis 202
Differential contribution of bradykinin receptors in angiogenesis 201
The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor 199
Pharmacological inhibition of microsomal prostaglandin e synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis. 199
Derivati 4-sostituiti della 1-(2-cloro-2-feniletil)-1H-pirazolo[3,4-d]pirimidina e loro usi. 198
Angiogenesis 196
Nitric oxide in tumor angiogenesis 193
PKCε ACTIVATION PROMOTES FGF-2 EXOCYTOSIS AND INDUCES ENDOTHELIAL CELL PROLIFERATION AND SPROUTING 191
Nitric oxide releasing metal-diazeniumdiolate complexes strongly induce vasorelaxation and endothelial cell proliferation 190
Nitric oxide synthase lies downstream of vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis 189
Molecular mechanisms of resistance to anti-angiogenic drugs 188
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents 187
Angiotensin II potentiates the mitogenic effect of noradrenaline in vascular smooth muscle cells via AT1 receptors 185
Expression and localization of placenta growth factor and PlGF receptors in human meningiomas 185
Targeting Integrins in Cancer 185
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 184
Nitric oxide and angiogenesis 182
By-products from winemaking and olive mill value chains for the enrichment of refined olive oil: Technological challenges and nutraceutical features 182
Chapter 2. Antiangiogenic drugs: Chemosensitizers for combination cancer therapy 182
Effect of Hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A: role of flt-1/VEGF-receptor-1 180
Inflammation and tumor progression: role of prostaglandin E2 pathway 176
PKCepsilon activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting 175
Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk 175
deltaPKC inhibition or epsilonPKC activation repairs endothelial vascular dysfunction by regulating eNOS post-translational modification 174
Oxidative Stress and Membrane Transport Systems 174
Repurposing of drugs for triple negative breast cancer: an overview 174
Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway 172
First-line pharmacotherapies and survival among patients diagnosed with non-resectable NSCLC: a real-life setting study with gender prospective 171
Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress 169
Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto chick chorioallantoic membrane: endothelial fenestration and angiogenesis 169
Use of Nutraceuticals in Angiogenesis-Dependent Disorders 169
Development of fortified citrus olive oils: From their production to their nutraceutical properties on the cardiovascular system 168
Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1 167
Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4 166
Scoping Review on Platelets and Tumor Angiogenesis: Do We Need More Evidence or Better Analysis? 165
Molecular mechanisms of VEGF-induced angiogenesis 165
ETB receptors promote proliferation and migration of endothelial cells 164
Constitutive and inducible nitric oxide synthase: role in angiogenesis 163
Hydrogen peroxide mediates endothelium-dependent dilation of coronary arterioles in obese rats on low carbohydrate diet 163
Novel tyrosine kinase inhibitors active against a wide panel of tumor cell lines 162
Mitochondrial aldehyde dehydrogenase-2 activation prevents β amyloids induced endothelial cell dysfunction and restores angiogenesis. 162
alpha(1D)-adrenoceptors cause endothelium-dependent vasodilatation in the rat mesenteric vascular bed 159
Linking regional administrative data with an hospital pathology registry in Italy to describe first-line pharmacotherapy of non-resectable non-small cell lung cancer in 2009-2017 159
Low concentration of cetuximab treatment combined with DPE, a polyphenol of extra virgin olive oil, reduces colorectal cancer cell growth 158
Nitric oxide and PGE-2 cross-talk in EGFR-driven epithelial tumor cells 158
ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium 157
Endostatin: a promising drug for antiangiogenic therapy 156
Totale 21.642
Categoria #
all - tutte 78.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.375


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021287 0 0 0 0 0 0 0 0 0 0 0 287
2021/20221.631 86 230 88 197 76 80 70 64 57 156 168 359
2022/20232.289 136 194 301 330 217 477 46 173 235 54 67 59
2023/20241.671 63 38 105 144 45 511 582 41 4 19 14 105
2024/20253.328 67 177 321 251 362 192 79 181 272 129 412 885
2025/20268.377 685 1.110 993 929 1.701 293 1.286 224 341 457 219 139
Totale 25.674